Lupin Ltd (LUPN.NS)
Drugmaker Lupin Ltd posted a bigger-than-expected fall in first-quarter profit on Wednesday, hurt by declining sales in the United States and Japan.
Aug 8 Drugmaker Lupin Ltd posted a bigger-than-expected fall in first-quarter profit on Wednesday, hurt by declining sales in the United States and Japan.
Aug 8 Drugmaker Lupin Ltd posted a 43 percent fall in first-quarter profit on Wednesday, widely missing analysts' estimates.
Aug 3 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of August 2, 2018. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINAGS: ------------------- Aditya Birla Capital Ltd
** April-June quarter should be weak for Cadila Healthcare Ltd and Lupin Ltd with sharp declines in U.S. sales q-o-q - Credit Suisse (CS)
India's second-largest drugmaker Lupin Ltd said on Wednesday it expected pressure on drug prices in the United States, which has hit its profits, to ease this year as larger rivals reduce their exposure there.
* U.S. sales fall 21.1 pct; India sales up 14 pct (Adds management comments from conference call)
May 15 Lupin Ltd, India's second-largest drugmaker by revenue, reported a surprise loss in its fiscal fourth quarter on Tuesday, due to a one-time charge.
* MARCH QUARTER CONSOL NET LOSS 7.84 BILLION RUPEES VERSUS PROFIT OF 3.80 BILLION RUPEES LAST YEAR
* LAUNCHES CORCAL BONE AND BEAUTY SUPPLEMENT Source text: http://bit.ly/2I8514t Further company coverage: